GlobeNewswire

Shell Invests in LanzaJet to Further Accelerate the Global Commercialization of LanzaJet’s Leading Alcohol-to-Jet Technology to Address the Aviation Sector’s Urgent Need to Decarbonise

Share

CHICAGO, April 06, 2021 (GLOBE NEWSWIRE) -- Our world is at an inflection point - one that requires action today, solutions that work, and meaningful progress toward decarbonizing industries and our society. LanzaJet, Inc., a leading sustainable fuels technology company and sustainable fuels producer, announced today that Shell joins as an investor in the company to advance LanzaJet’s global growth, accelerate commercialization of its technology, and scale the production of Sustainable Aviation Fuel (SAF).

Shell joins founding investors in LanzaJet, including LanzaTech, Suncor Energy Inc., Mitsui & Co., Ltd., and more recently, British Airways, as well as participation from All Nippon Airways. In addition to its initial investment in LanzaJet and similar to the phased investment approach used with all of the LanzaJet investors, Shell will have the opportunity to make further investments in the construction of larger-scale production facilities over the coming years. This innovative phased investment approach significantly accelerates commercial deployment at a time when reducing emissions, especially of aviation, is increasingly important and demonstrates a joint commitment to creating a resilient, low carbon future. With the right policies to support the uptake and production of SAF, aviation can achieve net-zero emissions.

The investment comes as LanzaJet continues its work to build the first Alcohol-to-Jet (AtJ) facility of its’ kind globally, a commercial-scale plant (10 million gallons per year capacity) in Soperton, Georgia, USA. Freedom Pines Fuels, as it's called, continues on schedule with operations beginning in 2022. LanzaJet was launched in June 2020 following nearly a decade of technology development and commercial scale-up through a partnership by LanzaJet’s founder, LanzaTech, with the U.S Department of Energy’s Pacific Northwest National Laboratory (PNNL).  The LanzaJet process can use any source of sustainable ethanol for jet fuel production, including, but not limited to, ethanol made from recycled pollution, the core application of LanzaTech’s carbon recycling platform.  

LanzaJet’s technology is uniquely able to produce up to 90% of its fuels as SAF, with the remaining 10% as renewable diesel. The SAF will be blended with conventional fossil jet fuel and be supplied to airports through the existing supply routes. The technology can flex to produce more diesel and less SAF, as desired. LanzaJet’s SAF is approved to be blended up to 50% with fossil jet fuel, the maximum allowed by ASTM, and is a drop-in fuel that requires no modifications to engines, aircraft, and infrastructure. Additionally, LanzaJet’s SAF delivers more than a 70% reduction in greenhouse gas emissions on a lifecycle basis, compared to conventional fossil jet fuel. The versatility in ethanol, and a focus on low-carbon, waste-based, and non-food /non-feed sources, along with ethanol’s global availability, make LanzaJet’s technology a relevant and enduring solution for SAF.

Anna Mascolo, President, Shell Aviation, said:

"LanzaJet's technology opens up a new and exciting pathway to produce SAF using an AtJ process and will help address the aviation sector's urgent need for SAF. It demonstrates that the industry can move faster and deliver more when we all work together. Provided industry, government and society collaborate on appropriate policy mechanisms and regulations to drive both supply and demand, aviation can achieve net-zero carbon emissions. The strategic fit with LanzaJet is exciting. Through our Raízen joint venture in Brazil, we have been producing bioethanol for over ten years, and we have already demonstrated production of cellulosic ethanol from waste materials. Our access to feedstocks, experience of optimizing supply chains, and extensive sales and marketing business will hopefully contribute to LanzaJet creating sustainable, robust, and scalable commercial operations, supporting our customers’ decarbonisation ambitions for many years to come.”

Jimmy Samartzis, LanzaJet CEO, said:

"We’ve been at a crossroads for years and we’re now at a point in time when real solutions matter to address the global need to get to net-zero. At LanzaJet, we’re in a unique position with technology that is ready and scaling today to produce lower-carbon, sustainable fuels. Shell’s investment and partnership help to further advance our work to do our part to decarbonize aviation globally, a sector with limited other options in the near- and mid-term.”

Jennifer Holmgren, LanzaJet Board Chair and LanzaTech CEO, said:

"We have an outstanding group of investors, leading in the energy transition and working across industries to reduce carbon emissions. I am delighted to welcome Shell to the LanzaJet family as we work together to realize our ambition of producing significant volumes of SAF from wastes to help the aviation sector meet their carbon reduction goals.”

Quick Facts

  • Sustainable Aviation Fuel (SAF) is fundamental to aviation’s progress towards net-zero emissions, and looking forward, LanzaJet’s technology provides a ready, scalable, and unique solution that focuses on SAF production today and for tomorrow.
  • Shell’s investment further enables LanzaJet’s global growth and aligns with Shell’s strategy to become a net-zero emissions energy business by 2050, in step with society, providing customers with more and cleaner energy solutions.
  • Shell joins other LanzaJet investors including LanzaTech, Suncor Energy Inc., Mitsui & Co., Ltd., and British Airways, along with participation in LanzaJet by All Nippon Airways (ANA).

Ends

Attachments


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Notification according to chapter 9, section 10 of the Securities Market Act: Bolero Holdings SARL ownership in Suominen decreases to below 5 percent16.4.2021 15:30:00 CEST | Press release

Suominen Corporation, stock exchange release on April 16, 2021 at 4.30 p.m. (EET). Suominen Corporation has on April 16, 2021 received a notification referred to in Chapter 9, Section 5 and 6 of the Securities Market Act. According to the notification, the shareholding of Bolero Holdings SARL in Suominen Corporation has fallen below the 5% flagging threshold. Total positions of person subject to the notification obligation: % of shares and voting rights (total of 7.A)% of shares and voting rights through financial instruments (total of 7.B)Total of both in % (7.A + 7.B)Total number of shares and voting rights of the issuerResulting situation on the date on which threshold was crossed or reachedBelow 5%n/aBelow 5%58,259,219Position of previous notification (if applicable)5.81%n/a5.81% Notified details of the resulting situation on the date on which the threshold was crossed or reached: A: Shares and voting rightsClass/type of sharesNumber of shares and voting rights% of shares and votin

Correction: REGARDING DRAFT ALTERNATIVE RESOLUTION SUBMITTED TO THE ANNUAL GENERAL MEETING OF SHAREHOLDERS16.4.2021 14:49:32 CEST | Press release

Correction: the number of shares indicated – 380.396.585 and declared dividends per share – 0,0198 EUR. On 15 April 2021 AB “Klaipėdos nafta” (hereinafter – Company) received a proposal from the Ministry of Energy of the Republic of Lithuania (hereinafter referred to as the Shareholder), that executes the rights of the Shareholder – the Republic of Lithuania that owns 275 687 444 ordinary registered shares, making 72,45 per cent of the total amount of the Company’s shares, on an alternative draft resolution of the issue on the agenda of the ordinary registered meeting of shareholders of the Company to be convened on 30 April 2021. Following paragraphs 3, 4 and 5 of Article 25 of the Law on Companies of the Republic of Lithuania, the Shareholder as the person exercising the right to propose draft resolutions of the Company’s General Meeting, holding shares that grant at least 1/20 of all the votes, proposes to approve the following draft resolution of the fourth item on the agenda of th

Sampo plc: Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.)16.4.2021 14:30:00 CEST | Press release

SAMPO PLC STOCK EXCHANGE RELEASE 16 April 2021 at 3:30 pm Disclosure Under Chapter 9 Section 5 of the Securities Market Act (BlackRock, Inc.) Sampo plc (business code 0142213-3) has received a disclosure under Chapter 9, Section 5 of the Securities Markets Act, according to which the total number of voting rights attached to Sampo A shares (ISIN: FI009003305) owned directly, indirectly or through financial instruments by BlackRock, Inc. (USA tax ID 32-0174421) and its funds increased on 15 April 2021 above five (5) per cent of Sampo plc’s total voting rights. In addition, the disclosure obligation arose due to the number of Sampo A shares owned directly or indirectly by BlackRock, Inc. and its funds increasing above 5 per cent. Sampo's share capital comprises 555,351,850 shares, of which 554,151,850 are A shares and 1,200,000 are B shares. Each A share entitles its holder to one (1) vote and each B share to five (5) votes. Thus, the total number of votes is 560,151,850. Total positions

CrossAmerica Partners to Announce First Quarter 2021 Earnings Results on May 1016.4.2021 12:45:00 CEST | Press release

Allentown, April 16, 2021 (GLOBE NEWSWIRE) -- CrossAmerica Partners to Announce First Quarter 2021 Earnings Results on May 10 ALLENTOWN, PA, April 16, 2021 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its first quarter 2021 results after the market closes on Monday, May 10, 2021. In conjunction with the news release, management will host a conference call on Tuesday, May 11, at 9:00 a.m. Eastern Time. The conference call numbers are 800-774-6070 or 630-691-2753 and the passcode for both is 7265208#. A live audio webcast of the conference call and the related earnings materials, including reconciliations of any non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, will be available on that same day on the investor section of the CrossAmerica website (www.crossamericapartners.com). To listen to the audio webcast, go to https://caplp.gcs-web.com/webcasts-presentations https://caplp.gcs-web.com/webcasts-presentations. A

Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD16.4.2021 11:00:00 CEST | Press release

Press release, Helsinki, 16.04.2021, 12.00 pm (EEST) Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that the company’s SmartFocus® nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with depression. Oladele Adebogun M.D. said, “I was initially introduced to Nexstim by the early outcomes of their registry which showed 50% remission rates in a small number of patients suffering from major depressive disorder. I purchased my first system and have been so impressed with my own patient outcomes that I have added this second system for my patients located in Flower Mound, Texas. I have even been able to successfully treat those patients who failed to respond to TMS on our prior non-Nexstim system. I am proud to contribute to the latest Nexstim treatment outcomes of triple the number of pat

RESULT OF RIKSBANK REVERSED AUCTIONS SEK GOVERNMENT BONDS16.4.2021 10:08:23 CEST | Press release

Auction date2021-04-16Loan1062Coupon0.125 %ISIN-codeSE0013935319Maturity2031-05-12Tendered volume, SEK mln750 +/- 400Volume offered, SEK mln4,000Volume bought, SEK mln750Number of bids12Number of accepted bids3Average yield0.367 %Lowest accepted yield0.367 %Highest yield0.368 %% accepted at lowest yield 65.00 Auction date2021-04-16Loan1053Coupon3.50 %ISIN-codeSE0002829192Maturity2039-03-30Tendered volume, SEK mln500 +/- 250Volume offered, SEK mln1,400Volume bought, SEK mln500Number of bids5Number of accepted bids2Average yield0.696 %Lowest accepted yield0.693 %Highest yield0.698 %% accepted at lowest yield 100.00 Auction date2021-04-16LoanREGS Kingdom of SwedenCoupon0.125 %ISIN-codeXS2226974504Maturity2030-09-09Tendered volume, SEK mln250 +/- 250Volume offered, SEK mln600Volume bought, SEK mln250Number of bids6Number of accepted bids3Average yield0.287 %Lowest accepted yield0.281 %Highest yield0.291 %% accepted at lowest yield 50.00

Prostate cancer study to be initiated at Uppsala University Hospital with NanoZolid technology®16.4.2021 09:00:00 CEST | Press release

UPPSALA, SWEDEN – LIDDS AB (publ) announced today that an application for a new clinical study at Uppsala University Hospital has been submitted. The study will assess intratumoral injections of NZ-DTX Depot, containing the cytotoxic agent docetaxel, in men with prostate cancer who are scheduled for prostatectomy. The trial is originated by the principal investigator of the trial, Dr Michael Häggman, Associate Professor at the Department of Surgical Sciences in Urology, Uppsala University Hospital. The study is planned to start in mid of this year and it will enroll 10- 15 patients to be treated with NZ-DTX prior to planned surgery. “The NanoZolid technology is suitable to combine with the MRI/TRUS injection technique for a high precision intratumoral delivery of NZ-DTX Depot. Treating patients prior to removal of the prostate gland will provide exhaustive information with regards to local effects in the tumor and surrounding tissue”, commented Dr Michael Häggman. “We are very pleased